Literature DB >> 21586194

Psychiatric comorbidities in adolescents with attention-deficit hyperactivity disorder and their siblings.

Li-Kuang Yang1, Chi-Yung Shang, Susan Shur-Fen Gau.   

Abstract

OBJECTIVE: Despite high psychiatric comorbidities in adolescents with clinical diagnosis of attention-deficit hyperactivity disorder (ADHD), little is known about psychiatric comorbidities in their siblings. We investigated the psychiatric comorbid conditions in adolescents with ADHD, their siblings, and healthy control subjects from their school.
METHOD: The sample included 136 adolescent probands with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), diagnostic criteria; 136 siblings (47 affected and 89 unaffected) and 136 age- and sex-matched healthy school control subjects. All participants and their parents received the structured psychiatric interviews for current and lifetime DSM-IV psychiatric disorders of the participants.
RESULTS: The rate of ADHD (34.6%) in the siblings of probands with ADHD was about 7 times higher than in the general population. Probands with ADHD were significantly more likely than unaffected siblings (OR 6.38; 95% CI 3.43 to 11.88) and healthy school control subjects (OR 9.60; 95% CI 5.31 to 17.34) to have a DSM-IV psychiatric disorder, including oppositional defiant disorder (ODD), conduct disorder (CD), tic disorders, major depressive disorder, specific phobia (more than control subjects only), nicotine use disorder, and sleep disorders. The affected siblings were significantly more likely than healthy school control subjects to have ODD, CD, specific phobia, and to have consumed alcohol (ORs ranging from 2.30 to 20.16).
CONCLUSIONS: Our findings suggest that siblings of probands with ADHD have increased risks for ADHD and that the affected siblings have more psychiatric comorbidities than healthy school control subjects. It warrants early identification of ADHD symptoms and other psychiatric comorbid conditions as well in siblings of adolescents with ADHD.

Entities:  

Mesh:

Year:  2011        PMID: 21586194     DOI: 10.1177/070674371105600507

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

Review 1.  The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update.

Authors:  John J Mariani; Edward J Khantzian; Frances R Levin
Journal:  Am J Addict       Date:  2013-09-13

2.  Mother-Child Relationship in Youths with Attention-Deficit Hyperactivity Disorder and their Siblings.

Authors:  Jane Pei-Chen Chang; Susan Shur-Fen Gau
Journal:  J Abnorm Child Psychol       Date:  2017-07

Review 3.  Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.

Authors:  Jessica R Lunsford-Avery; Andrew D Krystal; Scott H Kollins
Journal:  Clin Psychol Rev       Date:  2016-10-23

4.  Behavioural Measures of Infant Activity but Not Attention Associate with Later Preschool ADHD Traits.

Authors:  Amy Goodwin; Alexandra Hendry; Luke Mason; Tessel Bazelmans; Jannath Begum Ali; Greg Pasco; Tony Charman; Emily J H Jones; Mark H Johnson; The Basis/Staars Team
Journal:  Brain Sci       Date:  2021-04-21

5.  Comorbid Depressive Disorders in ADHD: The Role of ADHD Severity, Subtypes and Familial Psychiatric Disorders.

Authors:  Michela Di Trani; Francesca Di Roma; Elda Andriola; Andriola Elda; Daniela Leone; Leone Daniela; Pasquale Parisi; Parisi Pasquale; Silvia Miano; Miano Silvia; Renato Donfrancesco; Donfrancesco Renato
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

6.  Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial.

Authors:  Amy Goodwin; Simona Salomone; Patrick Bolton; Tony Charman; Emily J H Jones; Andrew Pickles; Emily Robinson; Tim Smith; Edmund J S Sonuga-Barke; Sam Wass; Mark H Johnson
Journal:  Trials       Date:  2016-12-28       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.